American Banking and Market News logo

The Latest Headlines at American Banking and Market News

Image about Andean Precious Metals (CVE:APM) Upgraded to Moderate Buy at Desjardins

Andean Precious Metals (CVE:APM) Upgraded to Moderate Buy at Desjardins

Desjardins upgraded shares of Andean Precious Metals (CVE:APM – Free Report) to a moderate buy rating in a research report released on Thursday, Zacks.com reports. Andean Precious Metals Trading Down 7.3 % CVE:APM opened at C$1.65... More of this article »
Image about Adeia’s (ADEA) “Buy” Rating Reiterated at Rosenblatt Securities

Adeia’s (ADEA) “Buy” Rating Reiterated at Rosenblatt Securities

Rosenblatt Securities reaffirmed their buy rating on shares of Adeia (NASDAQ:ADEA – Free Report) in a report issued on Thursday, Benzinga reports. The firm currently has a $15.00 target price on the stock. Separately, BWS Financial... More of this article »
Image about Robert W. Baird Has Lowered Expectations for Advanced Energy Industries (NASDAQ:AEIS) Stock Price

Robert W. Baird Has Lowered Expectations for Advanced Energy Industries (NASDAQ:AEIS) Stock Price

Advanced Energy Industries (NASDAQ:AEIS – Get Free Report) had its price objective decreased by analysts at Robert W. Baird from $128.00 to $124.00 in a report released on Friday, Benzinga reports. The firm currently has an... More of this article »
Image about Alumis (NASDAQ:ALMS) Upgraded at Baird R W

Alumis (NASDAQ:ALMS) Upgraded at Baird R W

Baird R W upgraded shares of Alumis (NASDAQ:ALMS – Free Report) to a strong-buy rating in a research note published on Thursday morning, Zacks.com reports. A number of other equities analysts also recently commented on the company.... More of this article »
Image about Advanced Energy Industries (NASDAQ:AEIS) Price Target Lowered to $118.00 at TD Cowen

Advanced Energy Industries (NASDAQ:AEIS) Price Target Lowered to $118.00 at TD Cowen

Advanced Energy Industries (NASDAQ:AEIS – Free Report) had its price objective reduced by TD Cowen from $120.00 to $118.00 in a research note released on Thursday, MarketBeat.com reports. They currently have a hold rating on... More of this article »
Image about Monument Mining (CVE:MMY) PT Set at C$0.56 by Fundamental Research

Monument Mining (CVE:MMY) PT Set at C$0.56 by Fundamental Research

Fundamental Research set a C$0.56 price objective on Monument Mining (CVE:MMY – Free Report) in a report published on Wednesday, BayStreet.CA reports. The brokerage currently has a buy rating on the stock. Monument Mining Price... More of this article »
Image about Aeterna Zentaris (NASDAQ:AEZS) Earns Sell Rating from Analysts at StockNews.com

Aeterna Zentaris (NASDAQ:AEZS) Earns Sell Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a research note published on Thursday. The firm issued a sell rating on the biopharmaceutical company’s stock. Aeterna... More of this article »
Image about Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock Price Expected to Rise, Canaccord Genuity Group Analyst Says

Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock Price Expected to Rise, Canaccord Genuity Group Analyst Says

Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) had its price objective increased by equities researchers at Canaccord Genuity Group from $366.00 to $384.00 in a report released on Friday, Benzinga reports. The brokerage... More of this article »
Image about Aethlon Medical (NASDAQ:AEMD) Coverage Initiated by Analysts at StockNews.com

Aethlon Medical (NASDAQ:AEMD) Coverage Initiated by Analysts at StockNews.com

StockNews.com began coverage on shares of Aethlon Medical (NASDAQ:AEMD – Free Report) in a report issued on Thursday morning. The brokerage issued a sell rating on the medical equipment provider’s stock. Aethlon Medical... More of this article »
Image about Royal Bank of Canada Lowers Arch Capital Group (NASDAQ:ACGL) Price Target to $125.00

Royal Bank of Canada Lowers Arch Capital Group (NASDAQ:ACGL) Price Target to $125.00

Arch Capital Group (NASDAQ:ACGL – Get Free Report) had its target price lowered by Royal Bank of Canada from $128.00 to $125.00 in a research note issued to investors on Friday, Benzinga reports. The firm presently has an “outperform”... More of this article »
Image about Agilysys (NASDAQ:AGYS) Downgraded by StockNews.com to Hold

Agilysys (NASDAQ:AGYS) Downgraded by StockNews.com to Hold

StockNews.com downgraded shares of Agilysys (NASDAQ:AGYS – Free Report) from a buy rating to a hold rating in a report published on Thursday. A number of other research analysts also recently weighed in on the company. BTIG Research... More of this article »
Image about UBS Group Forecasts Strong Price Appreciation for Alignment Healthcare (NASDAQ:ALHC) Stock

UBS Group Forecasts Strong Price Appreciation for Alignment Healthcare (NASDAQ:ALHC) Stock

Alignment Healthcare (NASDAQ:ALHC – Free Report) had its price target boosted by UBS Group from $9.00 to $12.00 in a report released on Wednesday, Benzinga reports. The brokerage currently has a neutral rating on the stock. Other... More of this article »
Image about PENG (PENG) versus Its Competitors Head-To-Head Contrast

PENG (PENG) versus Its Competitors Head-To-Head Contrast

PENG (NASDAQ:PENG – Get Free Report) is one of 174 publicly-traded companies in the “Semiconductors & related devices” industry, but how does it compare to its peers? We will compare PENG to similar companies... More of this article »
Image about Amneal Pharmaceuticals (NASDAQ:AMRX) versus Zai Lab (NASDAQ:ZLAB) Financial Review

Amneal Pharmaceuticals (NASDAQ:AMRX) versus Zai Lab (NASDAQ:ZLAB) Financial Review

Zai Lab (NASDAQ:ZLAB – Get Free Report) and Amneal Pharmaceuticals (NASDAQ:AMRX – Get Free Report) are both mid-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength... More of this article »
Image about Head to Head Analysis: 4D Molecular Therapeutics (NASDAQ:FDMT) vs. Apogee Therapeutics (NASDAQ:APGE)

Head to Head Analysis: 4D Molecular Therapeutics (NASDAQ:FDMT) vs. Apogee Therapeutics (NASDAQ:APGE)

4D Molecular Therapeutics (NASDAQ:FDMT – Get Free Report) and Apogee Therapeutics (NASDAQ:APGE – Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based on... More of this article »